Skip to Content

Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Class H GZPHF

Rating as of

Morningstar’s Analysis

Currency in USD
Is it the right time to buy or sell?
Find out with Morningstar Premium
Is it the right time to buy or sell?
Find out with Morningstar Premium

1-Star Price


5-Star Price


Economic Moat


About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Company Profile

Business Description

Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd is active in the Chinese healthcare sector. The company manufactures pharmaceutical products including antibiotics, vasodilators, and traditional Chinese medical therapies in preparations such as injection, tablet, capsule, powder, cream, and oral liquid. Its operations are divided into three main segments: pharmaceutical manufacturing, pharmaceutical distribution & retail, and health products. The greater portion of its revenue comes from its pharmaceutical activities in patent medicine, raw materials, distribution, and retail. The rest of its revenues come from its beverage, food, cosmetics, and health products. The company's primary market is China.

89 Queensway, Room 2005, 20th Floor
Guangzhou City, Hong Kong
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Most Recent Earnings Sep 30, 2021
Fiscal Year End Dec 31, 2020
Stock Type
Employees 24,825